Pfizer Company
Discover the commonalities and differences between biologics vs. biosimilars — especially when it comes to cost.
Invests into
Connections from
Founded Date:
1849-01-01
Total Funding:
31000000000
Investor Type:
Corporate Venture Capital
Employee Number:
10001+
Investment Stage:
Undisclosed
Funding Status:
Post-IPO Debt
Number Of Exists:
19
Technology:
Biotechnology
Last Funding Type:
Post-IPO Debt
Acquisitions Number:
Made Acquisitions
Investors Number:
44
Last Funding Date:
2023-05-16
Zip:
NA
Industry:
Global Health
Headquarters:
USA
Estimated Revenue:
US$58.5 billion